Novelion Therapeutics (NVLN) Reports Q1 EPS of $0.47, Beats on Revenues; Reiterates FY17 Revenue Guidance

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 8/13/2026

1. CSCO
2. CBRS
3. COHR
4. WYFI
5. STUB
6. EAT
7. SPY
8. ANDG
9. GO
10. CRS

Go back to Novelion Therapeutics (NVLN) Reports Q1 EPS of $0.47, Beats on Revenues; Reiterates FY17 Revenue Guidance
(NASDAQ: NVLN) Delayed: 0.68 --0 (-0%)
Previous Close $0.68    52 Week High $ 
Open $0.01    52 Week Low $ 
Day High $0.68    P/E N/A 
Day Low $0.68    EPS $ 
Volume 408,294